Literature DB >> 28576177

Updates in the Treatment of Breast Cancer with Radiotherapy.

Serguei A Castaneda1, Jon Strasser2.   

Abstract

Breast-conserving therapy is one of the most remarkable achievements of modern cancer care. The authors review the evidence supporting the role of adjuvant radiotherapy as the standard of care for breast cancer after breast-conserving surgery, consensus guidelines for margins in invasive cancer disease and ductal carcinoma in situ, the role of partial-breast irradiation and hypofractionated whole-breast irradiation, and the evolving indications for postmastectomy radiation therapy and extent of nodal coverage. Areas of research include specific methods of partial-breast irradiation, interactions between neoadjuvant chemotherapy and radiotherapy, and integration of molecular profiles with the selection of the best treatment modality and timing.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Accelerated partial-breast irradiation; Breast cancer; Breast neoplasms; Hypofractionated whole-breast irradiation; Intensity-modulated radiotherapy; Radiotherapy; Toxicity

Mesh:

Year:  2017        PMID: 28576177     DOI: 10.1016/j.soc.2017.01.013

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  39 in total

1.  An Uncommon Pairing of common Tumors: Case Report of Ductal Carcinoma in situ Within Fibroadenoma.

Authors:  Ashley Marumoto; Susan Steinemann; Nancy Furumoto; Stacey Woodruff
Journal:  Hawaii J Med Public Health       Date:  2019-02

Review 2.  Long Non-coding RNA ZFPM2-AS1: A Novel Biomarker in the Pathogenesis of Human Cancers.

Authors:  Gabriel B K Sasa; Cheng Xuan; Guoliang Lyu; Xianfeng Ding; Fang Meiyu
Journal:  Mol Biotechnol       Date:  2022-01-31       Impact factor: 2.695

3.  STAT1 mediated long non-coding RNA LINC00504 influences radio-sensitivity of breast cancer via binding to TAF15 and stabilizing CPEB2 expression.

Authors:  Jinchun Feng; Yan Li; Liping Zhu; Qian Zhao; Dan Li; Yuxiang Li; Tao Wu
Journal:  Cancer Biol Ther       Date:  2021-12-15       Impact factor: 4.742

4.  Integration of immune and hypoxia gene signatures improves the prediction of radiosensitivity in breast cancer.

Authors:  Derui Yan; Shang Cai; Lu Bai; Zixuan Du; Huijun Li; Peng Sun; Jianping Cao; Nengjun Yi; Song-Bai Liu; Zaixiang Tang
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

Review 5.  Radiation-Induced Tissue Damage: Clinical Consequences and Current Treatment Options.

Authors:  Hillary Nepon; Tyler Safran; Edward M Reece; Amanda M Murphy; Joshua Vorstenbosch; Peter G Davison
Journal:  Semin Plast Surg       Date:  2021-09-10       Impact factor: 2.195

6.  Radiation-induced undifferentiated pleomorphic sarcoma of the breast.

Authors:  Joshua Kong; Awni D Shahait; Steve Kim; Lydia Choi
Journal:  BMJ Case Rep       Date:  2020-02-10

Review 7.  The Roles of circMTO1 in Cancer.

Authors:  Wei Liu; Yuanyuan Xiong; Renhua Wan; Renfeng Shan; Jianfeng Li; Wu Wen
Journal:  Front Cell Dev Biol       Date:  2021-06-30

8.  Rosmanol induces breast cancer cells apoptosis by regulating PI3K/AKT and STAT3/JAK2 signaling pathways.

Authors:  Dongjun Jiang; Jiaqi Xu; Sitong Liu; Moussa Ide Nasser; Wei Wei; Tianjiao Mao; Xintong Liu; Xiaopan Zou; Jiang Li; Xiaomeng Li
Journal:  Oncol Lett       Date:  2021-07-01       Impact factor: 2.967

9.  Development of a Novel Prognostic Signature Based on Antigen Processing and Presentation in Patients with Breast Cancer.

Authors:  Aoshuang Qi; Mingyi Ju; Yinfeng Liu; Jia Bi; Qian Wei; Miao He; Minjie Wei; Lin Zhao
Journal:  Pathol Oncol Res       Date:  2021-04-01       Impact factor: 3.201

10.  Effects of Ulinastatin on Proliferation and Apoptosis of Breast Cancer Cells by Inhibiting the ERK Signaling Pathway.

Authors:  Zeyu Xing; Xin Wang; Jiaqi Liu; Gang Liu; Menglu Zhang; Kexin Feng; Xiang Wang
Journal:  Biomed Res Int       Date:  2021-07-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.